Nexentis Technologies Inc. (NXTS) vs Arcadia Biosciences, Inc. (RKDA)
A side-by-side comparison of Nexentis Technologies Inc. and Arcadia Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
NXTS
Nexentis Technologies Inc.
$1.39Basic MaterialsDelayed quote: Oct 6, 2026, 12:57 PM EDT
RKDA
Arcadia Biosciences, Inc.
$0.29Basic MaterialsDelayed quote: Oct 6, 2026, 12:51 PM EDT
Total return — NXTS vs RKDA
growth of $100 · dividends reinvested · last 1yNXTS -86.4% (-86.4%/yr)RKDA -87.3% (-87.3%/yr)NXTS compounded faster over this window
NXTS RKDA
NXTS vs RKDA: by the numbers
- •RKDA is the larger company ($449650 vs $78667 market cap).
- •Both run net losses; NXTS's is the smaller (0.00% vs -234.53% net margin).
Metrics side by side
Valuation
| Metric | NXTS | RKDA |
|---|---|---|
| P/S ratio | N/A | 0.09 |
| P/B ratio | 0.04 | 0.71 |
Profitability
| Metric | NXTS | RKDA |
|---|---|---|
| Gross margin | 0.00% | 34.58% |
| Operating margin | 0.00% | -205.74% |
| Net margin | 0.00% | -234.53% |
| ROE | -841.31% | -1758.45% |
| ROIC | -72.73% | -95.57% |
Growth (annualized)
| Metric | NXTS | RKDA |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -13.28% |
| Total return CAGR (5Y) | N/A | -67.74% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.